SCHEMBL17047211

SCHEMBL17047211

CC(=O)c1ccc2nccn2n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 11/20 0.55
CLK4 Q9HAZ1 3/20 0.55
JAK2 O60674 2/20 0.55
RET P07949 2/20 0.55
GSK3A P49840 2/20 0.55
RPS6KA3 P51812 2/20 0.55
LIMK1 P53667 2/20 0.55
MAP2K1 Q02750 2/20 0.55
ALK Q9UM73 2/20 0.55
DYRK1B Q9Y463 2/20 0.55
MAP4K4 O95819 2/20 0.55
PRKACA P17612 2/20 0.55
CDK8 P49336 2/20 0.55
LRRK2 Q5S007 2/20 0.55
AURKA O14965 1/20 0.55
DAPK3 O43293 1/20 0.55
ABL1 P00519 1/20 0.55
NTRK1 P04629 1/20 0.55
CSF1R P07333 1/20 0.55
FGFR1 P11362 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL877992 0.84 APOBEC3A (0.57) KDRCLK4JAK2RETGSK3A
SCHEMBL17303159 0.82 DYRK1A (0.45) KDRCLK4JAK2RETGSK3A
SCHEMBL297434 0.81 MAPK1 (0.47) KDRCLK4JAK2RETGSK3A
SCHEMBL30980401 0.78 NAMPT (0.50) KDRCLK4JAK2RETGSK3A
SCHEMBL21192982 0.78 CYP1A2 (0.45) KDRCLK4JAK2RETGSK3A
SCHEMBL9960608 0.78 KDR (0.54) KDRCLK4JAK2RETGSK3A
SCHEMBL9960616 0.77 KDR (0.53) KDRCLK4JAK2RETGSK3A
SCHEMBL9960611 0.77 KDR (0.53) KDRCLK4JAK2RETGSK3A
SCHEMBL22926416 0.76 JAK2 (0.75) KDRCLK4JAK2RETGSK3A
SCHEMBL13995847 0.74 APOBEC3A (0.73) KDRCLK4JAK2RETGSK3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3110802-B1 ETHYNYL DERIVATIVES HOFFMANN LA ROCHE (CH) 2018-10-10 EP disclosed
US-9725416-B2 Ethynyl derivatives HOFFMANN-LA ROCHE INC. (US) 2017-08-08 US disclosed
EP-3110802-A1 ETHYNYL DERIVATIVES F. Hoffmann-La Roche AG (CH) 2017-01-04 EP disclosed
US-20160362383-A1 ETHYNYL DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2016-12-15 US disclosed
WO-2015128307-A1 ETHYNYL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2015-09-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160362383-A1 ETHYNYL DERIVATIVES GRIA4, GRM4, GRM2 KDR 3523/4885CLK4 2195/4885JAK2 260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.